Scil Technology Acquires Rights to Worldwide Patents for CD-RAP from Roche Diagnostics GmbH
Scil Technology is using a recombinant version of CD-RAP (rhCD-RAP) as a cartilage growth factor in its cartilage regeneration programme. rhCD-RAP is highly specific for cartilage tissue. It has been shown to play a crucial role during cartilage formation in embryonic development and in the matrix stimulation of chondrocytes in adult animals. Furthermore it has been shown to stimulate cartilage synthesis in in vitro studies with chondrocytes from osteoarthritis patients. These properties make rhCD-RAP a highly promising candidate for cartilage regeneration in indications such as chondral defects and osteoarthritis.
Dr Irina Staatz-Granzer, Managing Director of Scil Technology, commented: "The acquisition of this patent completes our intellectual ownership of this promising cartilage growth factor, which gives us complete freedom to operate in using CD-RAP for the development of novel cartilage regenerative products ."
ST03A, Scil's lead regenerative cartilage product, is a biodegradable implant for the treatment of osteochondral defects such as knee injuries. It consists of a combination of rhCD-RAP and a carrier matrix allowing for controlled release of the growth factor to the defect site.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.